Washington State Makes Unprecedented $30 Million Investment in Cancer Research Through The CARE Fund

The Andy Hill Cancer Research Endowment (CARE) Fund is thrilled to announce that Washington State has made, in addition to existing funding levels, a special investment of $30 million in cancer research, to be granted by the CARE Fund. 

Cancer has been the leading cause of death in the state since 2004, and each year approximately 42,000 Washingtonians are diagnosed with cancer. The COVID-19 pandemic is expected to exacerbate the state's cancer death rate due to the pandemic's effect on patients and survivors suffering from delayed screening and prevention efforts and limiting diagnosis and treatment services.

In recognition of this great need, as well as our existing infrastructure of world-class cancer research and care, Washington State has made a special $30 million appropriation to the CARE Fund in the 2022 supplemental budget. 

In the words of the Senate bill that put forth this investment, “Action to promote cancer research and prevention to improve the quality of life of the people of Washington is consistent with this fundamental public purpose. It is the purpose of this act to provide additional sustained investment in cancer research at the Andy Hill CARE fund to make the program more robust. Increased investment in research is critical to saving lives and reducing the pain and suffering caused by cancer.”

Our board and staff are hard at work developing plans to invest these funds to advance cancer research projects in our state with the greatest potential to improve health outcomes, eliminate disparities and build lasting infrastructure. 

We look forward to sharing more information in the coming weeks as these plans are developed into RFPs. To receive updates on these and other opportunities, scroll to the bottom of this page to sign up for our newsletter.